Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Philicon Pharmaceuticals

Explore full profile

Producer of canned fruits, vegetables, and beverages

Nanjing City, ChinaFounded 2014Biotech & Life Sciences
Valuation $50–100M Last recorded · 2025
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Philicon Pharmaceuticals and the history behind them.

About Philicon Pharmaceuticals

Philicon-97 S.A. is a Bulgarian food and beverage company with a history spanning over 70 years. The company specializes in the production of fruit and vegetable products, including canned goods, juices, nectars, and drinks. Its product line features a wide variety of tomato-based items like sauces, ketchup, and purees, as well as traditional Bulgarian spreads such as lutenitsa. Philicon markets its products under several brands and is a prominent player in the local market.

Operating from Plovdiv, Bulgaria, the family-owned company emphasizes the use of ecologically clean fruits and vegetables to ensure product quality. Its manufacturing processes are certified by ISO 22000, IFS, and KOSHER standards. Philicon has a significant international presence, exporting its products to over 40 countries worldwide.

The company's business model is centered on producing and distributing a diverse portfolio of food and beverage products to both domestic and international markets. It serves consumers through retail channels, leveraging its long-standing brand recognition and reputation for quality.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2014
Headquarters
Nanjing City, China
Open positions
None listed
Dealroom signal
14.7/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotech & Life Sciences, Biotechnology, Biotech and Pharma, DT and LS, science-based
Links
Website

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC May 2025 $14M $55M Undisclosed ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Nanjing City HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Philicon Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Philicon Pharmaceuticals’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.